Reduced-intensity stem cell transplantation from an HLA-identical sibling donor in patients with myeloid malignancies

T. Hamaki, M. Kami, S. W. Kim, Y. Onishi, Y. Kishi, N. Murashige, A. Hori, R. Kojima, M. Sakiyama, O. Imataki, Y. Heike, R. Tanosaki, S. Masuo, S. Miyakoshi, S. Taniguchi, K. Tobinai, Y. Takaue

研究成果: Article査読

23 被引用数 (Scopus)

抄録

The purpose of this study was to evaluate the feasibility and efficacy of allogeneic hematopoietic stem cell transplantation with a reduced-intensity regimen (RIST) in patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). In all, 36 patients (median age 55 years) underwent RIST from an HLA-matched related donor between September 1999 and December 2002. The diagnoses included AML (n = 14), leukemia evolving from MDS (n = 10), and MDS (refractory anemia with excess blasts n = 6, refractory anemia n = 6). The RIST regimen consisted of purine analog (cladribine or fludarabine)/busulfan, with or without antithymocyte globulin. The regimen was well tolerated, and 34 patients achieved durable engraftment and most achieved remission after RIST. A total of 17 patients developed grade II-IV acute GVHD, and 27 developed chronic GVHD. Eight patients relapsed, and five of them received antithymocyte globulin (ATG) as part of the preparative regimen. A total of 12 patients died (four disease progression, six transplantation-related complications, and two others). Estimated 1-year disease-free survival (DFS) in low- and high-risk groups was 85 and 64%, respectively. We conclude that RIST can be performed safely in elderly patients with myeloid malignancies, and has therapeutic potential for those who fail conventional chemotherapy. In view of the significant association between GVHD or ATG and DFS, defined management of GVHD following RIST should become a major target of clinical research.

本文言語English
ページ(範囲)891-900
ページ数10
ジャーナルBone Marrow Transplantation
33
9
DOI
出版ステータスPublished - 2004 5
外部発表はい

ASJC Scopus subject areas

  • 血液学
  • 移植

フィンガープリント

「Reduced-intensity stem cell transplantation from an HLA-identical sibling donor in patients with myeloid malignancies」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル